ARCHIVES

Opioid Pain Reliever Approved With Risk Reduction Plan

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

NIH to Review Intramural Program: NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide Level

March 7, 2014

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012

Accuracy Of Diagnostic Mammograms Varies By Radiologist, Study Finds

December 28, 2007

Komen Under Pressure: Charity Faces Money Woes, Attacks from Right

October 26, 2012

ONS Membership Still Climbing, Soars over 15,000

June 23, 1989

Advances In Cancer Control Meeting Is Set For March 22

February 3, 1989